CREBBP and colorectal cancer: In testing against pancreatic and colorectal cancer cell lines expected to have a general P300/CBP dependence, we did not observe toxicities until concentrations of 0.3 μM and above, highlighting the extreme sensitivity of CIC-DUX4-induced cancers to iP300w.